Linagliptin improves glycemic control after 1 year as add-on therapy to basal insulin in Asian patients with type 2 diabetes mellitus

2015 ◽  
Vol 31 (3) ◽  
pp. 503-512 ◽  
Author(s):  
Wayne H.-H. Sheu ◽  
Sung Woo Park ◽  
Yan Gong ◽  
Sabine Pinnetti ◽  
Sudipta Bhattacharya ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Glycemic Control ◽  
Basal Insulin ◽  
Asian Patients

Pramlintide as an Adjunct to Basal Insulin: Effects on Glycemic Control and Weight in Patients with Type 2 Diabetes Mellitus

Insulin ◽  
2007 ◽  
Vol 2 (4) ◽  
pp. 166-172 ◽  
Author(s):  
Cameron W. Lush ◽  
Tamara Darsow ◽  
Bei Zhang ◽  
Gayle Lorenzi ◽  
Juan P. Frias
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Glycemic Control ◽  
Basal Insulin

scholarly journals Basal Insulin Dose Titration for Glycemic Control in Patients With Type 2 Diabetes Mellitus in Thailand: Results of the REWARDS Real-World Study

2020 ◽  
Vol 13 ◽  
pp. 117955142093593
Author(s):  
Chaicharn Deerochanawong ◽  
Rattana Leelawattana ◽  
Natapong Kosachunhanun ◽  
Puntip Tantiwong
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Glycemic Control ◽  
Real World ◽  
Basal Insulin ◽  
Insulin Dose ◽  
Dose Titration ◽  
Glycemic Targets

This multicenter, longitudinal, descriptive, observational study of T2DM adults in Thailand aimed to assess real-world outcomes of basal insulin (BI) dose titration on glycemic control. Three-hundred and twenty-four patients were recruited and followed up over 24 weeks. Basal insulin titration was physician-driven in 58.2% of patients and patient-driven in the rest. During the 24-week study period, the total daily BI dose moved from 20.9 to 25.6 in the physician-driven group, while in the patient-driven group, it increased from 25.3 to 29.7. Thirty-five patients (11.2%) achieved their individualized HbA1c targets, with 18 patients (5.8%) achieving HbA1c ⩽ 7% without documented hypoglycemia. In summary, this study highlights that BI titration is suboptimal in the real world, and patients are unable to achieve their glycemic targets.

scholarly journals Glycemic control and adherence to basal insulin therapy in Taiwanese patients with type 2 diabetes mellitus

2016 ◽  
Vol 7 (6) ◽  
pp. 881-888 ◽  
Author(s):  
Ming‐Nan Chien ◽  
Yen‐Ling Chen ◽  
Yi‐Jen Hung ◽  
Shu‐Yi Wang ◽  
Wen‐Tsung Lu ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Glycemic Control ◽  
Insulin Therapy ◽  
Basal Insulin
Sign in / Sign up

Export Citation Format

Share Document